Pharmbio Korea Co., Ltd.: Clinical Trials

17 trials sponsored by Pharmbio Korea Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 7 Phase 3, 5 Phase 4, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Unknown 3, Not yet recruiting 1
Phase 45Completed 4, Unknown 1
Phase 13Completed 2, Recruiting 1
Phase 22Completed 2

Follow Pharmbio Korea Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults
PBK_M2301 (levodropropizine + Pelargonium sidoides extract), R1_PBK_M2301 (levodropropizine), R2_PBK_M2301 (Pelargonium sidoides extract) - Healthy Volunteers
Phase 1RecruitingPharmbio Korea Co., Ltd.322025-08-272025-09-12
A Study to Evaluate Safety and Efficacy of PBK_M2502
PBK_M2502 1-Day, PBK_M2502 2-Day - Intestinal Disease, Colonic Diseases
Phase 3Not yet recruitingPharmbio Korea Co., Ltd.1102025-08-012025-08-11
Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults
R1_PBK_M2301(Levocloperastine 60mg), R2_PBK_M2301 (Pelargonium sidoides extract) - Drug-Drug Interaction Healthy Volunteers
Phase 1CompletedPharmbio Korea Co., Ltd.242025-06-012025-09-12
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
PBK_L2201, Placebo - Osteoporosis
Phase 3UnknownPharmbio Korea Co., Ltd.602024-02-012023-12-04
A Study to Evaluate Safety and Efficacy of PBK_M2101
PBK_M2101 2-Day, PBK_M2101 1-Day, Oral Sulfate Tablet 2-Day - Intestinal Disease, Colonic Diseases
Phase 3UnknownPharmbio Korea Co., Ltd.2462023-06-012023-06-28
Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea
PBK_L1704 0.35mg, PBK_L1704 0.5mg, Placebo - Acute Pain
Phase 3CompletedPharmbio Korea Co., Ltd.1822022-07-252026-01-30
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly
OST, 2L-PEG/Asc - Colonic Disease, Intestinal Disease
Phase 4UnknownPharmbio Korea Co., Ltd.2562022-02-012022-02-21
Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women
PBK-1801 - Healthy Volunteer
Phase 1CompletedPharmbio Korea Co., Ltd.362019-10-242020-06-05
Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy
PBK-1701TC, Standard oral preparation - Colonic Diseases, Intestinal Disease
Phase 3CompletedPharmbio Korea Co., Ltd.2352018-04-112018-11-26
Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid
Oral sulfate solution (OSS), 2-L PEG/Asc - Cathartic Colon
Phase 4CompletedBo-In Lee2002016-04-012017-10-11
The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
Somatostatin - Liver Failure
Phase 3UnknownKorea University Anam Hospital202015-07-012016-09-12
The Effects of High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy
Norzyme® 40000 IU, Placebo - Pancreaticoduodenectomy
Phase 4CompletedSeoul National University Hospital3042014-04-012019-01-07
Effect of Rowachol on Prevention of Postcholecystectomy Syndrome
Rowachol, Placebo - Postcholecystectomy Syndrome
Phase 4CompletedDongGuk University1382013-01-012014-11-21
Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia
Nefopam, Saline - Laparotomy
Phase 2 / Phase 3CompletedSeoul National University Hospital732012-10-012015-11-05
Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)
Norzyme - Pancreatic Cancer
Phase 2CompletedNational Cancer Center, Korea672011-10-012015-04-15
The Effect of Dexmedetomidine on Postoperative Analgesia
Fentanyl, Dexmedetomidine - Colon Cancer, Rectal Cancer
Phase 4CompletedSeoul National University Hospital952011-06-012012-03-08
Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea
Antibiotics Associated Colitis, Pulmonary Infection
CompletedPharmbio Korea Co., Ltd.2142009-01-012010-04-20

Conditions studied

Colonic Diseases (4)  ·  Intestinal Diseases (4)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Acute Pain (1)  ·  Colonic Neoplasms (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Liver Failure (1)  ·  Osteoporosis (1)  ·  Pancreatic Neoplasms (1)  ·  Postcholecystectomy Syndrome (1)  ·  Rectal Neoplasms (1)

Interventions

Dexmedetomidine (1)  ·  Fentanyl (1)  ·  Nefopam (1)  ·  Rowachol (1)  ·  Sodium Chloride (1)  ·  Somatostatin (1)  ·  Sulfates (1)  ·  dipropizine (1)  ·  pbk-1701TC (1)

Countries

South Korea (15)

Top investigators

Bo-In Lee, MD, PhD (1)  ·  Cha Jaemyeong, M.D, Ph.D (1)  ·  Dong-Sik Kim, Professor (1)  ·  Gang Hoseok, M.D, Ph.D (1)  ·  In Woong Han, M.D. (1)  ·  Jeong Yunho, M.D, Ph.D (1)  ·  Jin-Young Jang, M.D., PhD. (1)  ·  Na Suyeong, M.D, Ph.D (1)  ·  Sangmyung Woo, M.D (1)  ·  Seo Geomseok, M.D, Ph.D (1)  ·  SeungHwan Lee (1)  ·  Sung-Ae Jung, MD, PhD (1)

Results publications

PMID 27358262, PMID 27618657, PMID 30308546, PMID 31520730, PMID 38492010, PMID 41772803